A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF HYPERLIPIDEMIA, PROCESSES FOR PRODUCING THE SAME AND THE USE THEREOF

• Main Authors: GUO, ZHIXIN, LUO, RUIZHI, ZHU, GUOGUANG, WEI, FENG, YAN, XIJUN, YE, ZHENGLIANG, ZHANG, BOLI
• Format: Patent
• Language: English; French
• Published: 02.10.2012
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention discloses a pharmaceutical composition comprising Polygonum multiflorum Thunb, which comprises Polygonum multiflorum Thunb, Fructus Crataegi, Salvia miltiorrhiza Bunge and Radix Notoginseng. If needed, the pharmaceutical composition may comprise the pharmaceutically acceptable carriers. The weight ratio of Polygonum multiflorum Thunb, Salvia miltiorrhiza Bunge, Fructus Crataegi and Radix Notoginseng in the present composition is as follows: 10 to 20 parts of Polygonum multiflorum Thunb, 5 to 15 parts of Salvia miltiorrhiza Bunge, 10 to 20 parts of Fructus Crataegi and 1 to 10 parts of Radix Notoginseng. Also, the present invention discloses the methods for preparing the composition, including directly pulverizing the medicines into powder to produce the composition or preparing the medicines into the extracts and then make the extracts into drugs. The composition of the present invention has an effect of lowering blood lipid, and therefore can be used in preparation of drugs for treatment and/or prevention of hyperlipidemia. The present invention also discloses a method to treat and/or prevent hyperlipidemia. La présente invention concerne une composition pharmaceutique constituée de composants présents selon les parties en poids suivantes : Radix Polygoni Multiflori 10-20 parties, Radix Salviae Miltiorrhizae 5-15 parties, Fructus Crataegi 10-20 parties et Radix Notoginseng 1-10 parties. Si nécessaire, la composition peut contenir des excipients pharmaceutiques conventionnels. L~invention décrit également des procédés de production de la composition, l~utilisation de la composition pour la préparation d~un médicament destiné au traitement et/ou à la prévention de l~hyperlipidémie, ainsi que le procédé de traitement et/ou de prévention de l~hyperlipidémie. Les procédés de production de la composition comprennent les étapes consistant à broyer les composants directement et à formuler le mélange obtenu en substances pharmaceutiques, ou à extraire les composants afin de former d~abord un extrait, puis à formuler l~extrait obtenu en substances pharmaceutiques.